AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Salarius Pharmaceuticals, Inc. Director's Dealing 2018

Dec 27, 2018

35494_dirs_2018-12-27_f47ac05e-ed54-42fe-b767-d788999bb2c4.zip

Director's Dealing

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Flex Pharma, Inc. (FLKS)
CIK: 0001615219
Period of Report: 2018-12-20

Reporting Person: Boston Foundation, Inc. (10% Owner)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock, par value $0.0001	2200000	Direct